FGFR1–3 inhibitor

SI-6728

FGFR1–3 inhibitor, >98% (HPLC)

IUPAC Name : (E)-1-(4-(5-(4-Amino-3-(3,5-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pentyl)piperazin-1-yl)-4,4,4-trifluorobut-2-en-1-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : This is a covalent FGFR1–3 inhibitor that demonstrates potent antiproliferative activity in NCI‑H1581 and SNU‑16 cancer models, with low toxicity and favorable pharmacokinetics supporting its development as a drug candidate.

References : Wei Y. et al.: J. Med. Chem., 64(13), 9078-9099, 2021.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.